UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Guillain-Barré Syndrome After COVID-19 Infection in Korea: A Case Series

Journal of Korean Medical Science, 2024, 39(5), , pp.1-7

2024

Link zum Volltext

Verfügbarkeit prüfen

Coping with Dementia in the Middle of the COVID-19 Pandemic

Journal of Korean Medical Science, 2020, 35(42), , pp.1-21

2020

Link zum Volltext

Verfügbarkeit prüfen

A Novel Mutation in Sacsin, p.Val1335IIe, May Cause Late-Onset Sacsinopathy Due to Haploinsufficiency

Current issues in molecular biology, 2023-12, Vol.45 (12), p.9917-9925

2023

Link zum Volltext

Verfügbarkeit prüfen

The longest survivor of Creutzfeldt–Jakob disease with V180I mutation

Alzheimer's & dementia, 2021-12, Vol.17, p.e053144-n/a

Ryoo, Nayoung

2021

Link zum Volltext

Verfügbarkeit prüfen

Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment

Alzheimer's research & therapy, 2021-01, Vol.13 (1), p.10-10, Article 10

2021

Link zum Volltext

Verfügbarkeit prüfen

Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data

BMC medical informatics and decision making, 2022-11, Vol.22 (1), p.1-286, Article 286

2022

Link zum Volltext

Verfügbarkeit prüfen

Harnessing the Power of Voice: A Deep Neural Network Model for Alzheimer’s Disease Detection

Dementia and Neurocognitive Disorders(대한치매학회지), 2024, 23(1), 73, pp.1-10

2024

Link zum Volltext

Verfügbarkeit prüfen

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer's disease as an indicator of tau phosphorylation

Alzheimer's research & therapy, 2020-07, Vol.12 (1), p.83-83, Article 83

2020

Link zum Volltext

Verfügbarkeit prüfen

Coronavirus Disease 2019 and Dementia: The Survey for Dementia Patients in COVID-19 Crisis

Dementia and Neurocognitive Disorders(대한치매학회지), 2021, 20(2), 62, pp.16-17

2021

Link zum Volltext

Verfügbarkeit prüfen

Coronavirus Disease 2019 and Dementia: Recommendation of the Korean Dementia Association

Dementia and Neurocognitive Disorders(대한치매학회지), 2020, 19(4), 60, pp.125-128

2020

Link zum Volltext

Verfügbarkeit prüfen

Sustained Effect 1 Month After CSF Tap Test in Normal Pressure Hydrocephalus

Alzheimer's & dementia, 2023-06, Vol.19 (S2), p.n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Altered Brain Glymphatic Flow at Diffusion-Tensor MRI in Rapid Eye Movement Sleep Behavior Disorder

Radiology, 2023-06, Vol.307 (5), p.e221848-e221848

2023

Link zum Volltext

Verfügbarkeit prüfen

Idiopathic normal pressure hydrocephalus with synucleinopathy: Diagnosis and treatment

Alzheimer's & dementia, 2021-12, Vol.17 (S6), p.n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Neuropsychological factors related to progression of subjective cognitive decline

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Neuropsychological factors related to progression of subjective cognitive decline: Neuropsychology/Early detection of cognitive decline with neuropsychological tests

Alzheimer's & dementia, 2020-12, Vol.16 (S6)

2020

Link zum Volltext

Verfügbarkeit prüfen

Glymphatic function assessment in Parkinson's disease using diffusion tensor image analysis along the perivascular space

Parkinsonism & related disorders, 2023-09, Vol.114, p.105767-105767, Article 105767

2023

Link zum Volltext

Verfügbarkeit prüfen

Plasma amyloid‐β oligomerization tendency predicts amyloid PET positivity

Alzheimer's & dementia, 2023-06, Vol.19 (S2), p.n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Hypersensitivity to atypical antipsychotics in dementia with Lewy bodies: is it common or rare?

Parkinsonism & related disorders, 2020-07, Vol.76, p.44-45

2020

Link zum Volltext

Verfügbarkeit prüfen

Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-[beta] oligomerization data

BMC medical informatics and decision making, 2022-11, Vol.22 (1)

2022

Link zum Volltext

Verfügbarkeit prüfen

Posterior cortical atrophy syndrome: Asian study

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Posterior cortical atrophy syndrome: Asian study: Neuropsychiatry and behavioral neurology/Behavioral neurology

Alzheimer's & dementia, 2020-12, Vol.16 (S6)

2020

Link zum Volltext

Verfügbarkeit prüfen

Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer's Disease

Journal of Alzheimer's disease, 2020-01, Vol.75 (3), p.685

2020

Link zum Volltext

Verfügbarkeit prüfen

A Creutzfeldt–Jakob disease patient with V180I mutation survived for 16.5 years after diagnosis

Acta neurologica Belgica, 2022-02, Vol.122 (1), p.249-250

2022

Link zum Volltext

Verfügbarkeit prüfen

CSF total tau/α‐synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation

Alzheimer's & dementia, 2021-12, Vol.17 (S5), p.n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity

Clinical interventions in aging, 2021-01, Vol.16, p.749-755

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(41)
Berichte
(2)

Sprache

Englisch
(41)
Koreanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(13)
Neurosciences & Neurology
(8)
Clinical Neurology
(7)
Psychiatry
(7)
Alzheimer's Disease
(6)
Neurosciences
(5)
Age
(4)
Biomarkers
(4)
Cognitive Ability
(4)
Dementia
(4)
Original
(4)
Patients
(4)
Alzheimers Disease
(3)
Amyloid Beta-Protein
(3)
Bipolar Disorder
(3)
Carcinoma, Hepatocellular - Drug Therapy
(3)
Cross-Sectional Studies
(3)
General & Internal Medicine
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Guillain-Barré Syndrome After COVID-19 Infection in Korea: A Case Series

Coping with Dementia in the Middle of the COVID-19 Pandemic

A Novel Mutation in Sacsin, p.Val1335IIe, May Cause Late-Onset Sacsinopathy Due to Haploinsufficiency

The longest survivor of Creutzfeldt–Jakob disease with V180I mutation

Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment

Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data

Harnessing the Power of Voice: A Deep Neural Network Model for Alzheimer’s Disease Detection

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer's disease as an indicator of tau phosphorylation

Coronavirus Disease 2019 and Dementia: The Survey for Dementia Patients in COVID-19 Crisis

Coronavirus Disease 2019 and Dementia: Recommendation of the Korean Dementia Association

Sustained Effect 1 Month After CSF Tap Test in Normal Pressure Hydrocephalus

Altered Brain Glymphatic Flow at Diffusion-Tensor MRI in Rapid Eye Movement Sleep Behavior Disorder

Idiopathic normal pressure hydrocephalus with synucleinopathy: Diagnosis and treatment

Neuropsychological factors related to progression of subjective cognitive decline

Neuropsychological factors related to progression of subjective cognitive decline: Neuropsychology/Early detection of cognitive decline with neuropsychological tests

Glymphatic function assessment in Parkinson's disease using diffusion tensor image analysis along the perivascular space

Plasma amyloid‐β oligomerization tendency predicts amyloid PET positivity

Hypersensitivity to atypical antipsychotics in dementia with Lewy bodies: is it common or rare?

Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-[beta] oligomerization data

Posterior cortical atrophy syndrome: Asian study

Posterior cortical atrophy syndrome: Asian study: Neuropsychiatry and behavioral neurology/Behavioral neurology

Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer's Disease

A Creutzfeldt–Jakob disease patient with V180I mutation survived for 16.5 years after diagnosis

CSF total tau/α‐synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity

Suchergebnisse filtern